| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | YMAB | Common Stock | Sale | -$908K | -25K | -0.56% | $36.34* | 4.45M | May 28, 2021 | By WG Biotech ApS | F1, F3 |
| transaction | YMAB | Common Stock | Sale | -$244K | -6.86K | -0.15% | $35.57* | 4.45M | Jun 1, 2021 | By WG Biotech ApS | F2, F3 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $35.69 to $37.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $35.50 to $35.96. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares. |